Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
- 9 April 2007
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 61 (5), 396-402
- https://doi.org/10.1002/ana.21127
Abstract
The concept of neuroprotective therapy for acute ischemic stroke to salvage tissue at risk and improve functional outcome is based on sound scientific principles and extensive preclinical animal studies demonstrating efficacy. The failure of most neuroprotective drugs in clinical trials has been due to inadequate preclinical testing and flawed clinical development programs. The Stroke Therapy Academic Industry Roundtable (STAIR) group has outlined rational approaches to preclinical and clinical studies. The positive results from the first Stroke‐Acute‐Ischaemic‐NXY‐Treatment (SAINT‐I) trial of the free‐radical spin‐trap drug, NXY‐059, which followed many of the STAIR guidelines, reinvigorated enthusiasm in neuroprotection, but the SAINT‐II trial did not replicate the positive effect on the same primary prespecified outcome measure. This has led to concerns about the future of neuroprotection as a therapeutic strategy for acute ischemic stroke. We discuss new suggestions to bridge the chasm between preclinical animal modeling and acute human stroke trials to potentially enhance the future assessment of novel neuroprotective drugs. Ann Neurol 2007Keywords
This publication has 46 references indexed in Scilit:
- Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I TrialStroke, 2006
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)Stroke, 2006
- Perfusion-CT Assessment of Infarct Core and PenumbraStroke, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic StrokeStroke, 2005
- Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic StrokeStroke, 2003
- Recommendations for Clinical Trial Evaluation of Acute Stroke TherapiesStroke, 2001
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- Acute Stroke Therapy at the Millennium: Consummating the Marriage Between the Laboratory and BedsideStroke, 1999
- Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats.Stroke, 1994